Two Significant New Appointments in Horticulture and Compliance Advance Company Capabilities
DENVER, CO / CRWEPRESSRELEASE / August 19, 2015 / AmeriCann, Inc. (OTCMKTS:ACAN), a company with offices in Denver and Boston that designs, develops and owns large-scale advanced medical cannabis facilities, announced that it has added two additional members to its well-respected Advisory Board.
Dr. Brian A. Corr, a noted expert in controlled-environment horticulture, and Nickolas J. Brait, a licensed attorney specializing in the national cannabis industry, have joined the AmeriCann Advisory Board and will play key roles in the Company’s continuing aggressive national expansion plans.
AmeriCann’s Advisory Board consists of a carefully selected array of experts from a wide variety of disciplines – including medical research, plant sciences and seed genetics, greenhouse design, construction, operations, energy efficiency, quality control, licensing and regulatory compliance.
“Both Dr. Corr and Mr. Brait bring a superior level of experience and expertise to our Advisory Board,” stated Tim Keogh, CEO of AmeriCann.”It is becoming increasingly clear that this industry is in its infancy and that the future of cannabis is going to be largely based on research, plant science, building and operational efficiency.”
The cannabis industry has experienced explosive growth over the past two years and most experts believe this trend will accelerate as more states and nations join the movement toward the regulation and legalization of cannabis.
AmeriCann has become a recognized national leader in the design and development of state-of-the-art medical marijuana cultivation and processing laboratories. The Company now has over 1,000,000 square feet of sustainable, energy-efficient projects in development in multiple states and plans to enter additional states as they implement regulated cannabis programs.
“These team members have been collaborating with AmeriCann to provide advanced knowledge and specialized perspectives to help AmeriCann lead the industry into the future,” continued Mr. Keogh.
New Advisory Board member Dr. Corr stated, “From working with AmeriCann I recognize that we share a vision for the efficient and scientific production of the highest quality medical marijuana possible to provide relief to patients with intractable and debilitating diseases.”
Advisory Board member Nick Brait added, “As an attorney specializing in the cannabis industry nationally it has become apparent that the team at AmeriCann has a unique understanding of the enormous untapped potential this emerging industry offers. I’m very honored and excited to become a part of this team.”
Dr. Brian Corr
With over forty years of experience in controlled-environment horticulture, Dr. Corr is a well known and sought after expert in the scientific production of crops. He has been a faculty member at the University of Tennessee and has worked for international firms specializing in plant genetics. Over his long career he has traveled to over 30 countries to provide horticultural advice. At AmeriCann he will be responsible for new facility design, operations and product development.
Dr. Corr began his career in traditional agriculture and has earned three degrees including a PhD in plant sciences. He became a faculty member at the University of Tennessee specializing in controlled-environment horticulture. Later at the Ball Horticultural Company he managed a research greenhouse, directed research, had responsibility for international sales and was Director of New Crop Development.
Nickolas J. Brait, Attorney at Law
Mr. Brait is well-respected attorney licensed in Colorado and Arizona specializing exclusively in the legal regulated cannabis industry. He is the managing partner of the Denver-based Greene Law firm and a founder of the Cannabis Commodities Exchange of Colorado.
As a member of the AmeriCann Advisory Board, he will assist the company and its partners with license procurement in future states as well as the development of procedures to ensure AmeriCann’s cannabis facilities are compliant with state regulations and the highest industry standards.
He was a Distinguished Scholar at Southern Methodist University where he received his BBA in finance and a BA in political science before receiving his law degree from the University of Arizona.
AmeriCann, with offices in Denver and Boston, designs, develops and owns large-scale advanced medical cannabis facilities to produce the best possible medical cannabis in the most efficient manner utilizing advanced, sustainable practices. The Company has over 1,000,000 square feet of facilities in development in multiple states with plans to expand to additional states that have the greatest potential. AmeriCann does not cultivate, process or distribute cannabis, but partners with local businesses to serve marijuana patients in their communities. More information about the Company is available at: https://www.acaninfo.com
Forward-Looking Statements. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) (which Sections were adopted as part of the Private Securities Litigation Reform Act of 1995). Statements preceded by, followed by or that otherwise include the words “believe,” “anticipate,” “estimate,” “expect,” “intend,” “plan,” “project,” “prospects,” “outlook,” and similar words or expressions, or future or conditional verbs such as “will,” “should,” “would,” “may,” and “could” are generally forward-looking in nature and not historical facts. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company’s actual results, performance or achievements to be materially different from any anticipated results, performance or achievements. The Company disclaims any intention to, and undertakes no obligation to, revise any forward-looking statements, whether as a result of new information, a future event, or otherwise.